SCHEMBL21323017

SCHEMBL21323017

O=C(COc1ccccc1)N1CC2CN(C(=O)c3ccc4[nH]nnc4c3)CC2C1

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 2/20 0.43
▸ KMT2A Q03164 2/20 0.43
▸ NPC1 O15118 2/20 0.42
▸ RAB9A P51151 1/20 0.42
▸ CHRNB2 P17787 1/20 0.42
▸ CHRNB4 P30926 1/20 0.42
▸ CHRNA3 P32297 1/20 0.42
▸ CHRNA7 P36544 1/20 0.42
▸ CHRNA4 P43681 1/20 0.42
▸ ENPP2 Q13822 2/20 0.41
▸ DGAT2 Q96PD7 1/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ ATXN2 Q99700 8/20 0.41
▸ ALDH1A1 P00352 1/20 0.40
▸ KDM4E B2RXH2 1/20 0.39
▸ USP2 O75604 1/20 0.39
▸ GAA P10253 1/20 0.39
▸ LMNA P02545 1/20 0.39
▸ HTT P42858 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16963441 1.00 MEN1 (0.43) MEN1KMT2ANPC1RAB9ACHRNB2
SCHEMBL16963443 1.00 MEN1 (0.43) MEN1KMT2ANPC1RAB9ACHRNB2
SCHEMBL20101596 0.91 CYP3A4 (0.48) MEN1KMT2ANPC1RAB9AENPP2
SCHEMBL16963134 0.89 L3MBTL1 (0.41) ENPP2DGAT2L3MBTL1ATXN2LMNA
SCHEMBL16963137 0.89 L3MBTL1 (0.41) ENPP2DGAT2L3MBTL1ATXN2LMNA
SCHEMBL21322937 0.89 ATXN2 (0.42) ENPP2DGAT2ATXN2ALDH1A1
SCHEMBL16963548 0.89 ATXN2 (0.42) ENPP2DGAT2ATXN2ALDH1A1
SCHEMBL16963550 0.89 ATXN2 (0.42) ENPP2DGAT2ATXN2ALDH1A1
SCHEMBL21323007 0.88 ENPP2 (0.56) ENPP2DGAT2ATXN2
SCHEMBL16962303 0.88 ENPP2 (0.56) ENPP2DGAT2ATXN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2900669-B1 HEXAHYDROPYRROLO[3,4-C]PYRROLE DERIVATIVES AND RELATED COMPOUNDS AS AUTOTAXIN (ATX) INHIBITORS AND AS INHIBITORS OF THE LYSOPHOSPHATIDIC ACID (LPA) PRODUCTION FOR TREATING E.G. RENAL DISEASES HOFFMANN LA ROCHE (CH) 2019-09-04 — — EP disclosed
Send feedback